Instil Bio, Inc. Other Research and Development Expense
Instil Bio, Inc. (TIL) reported Other Research and Development Expense of $779.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2026-03-27
- Instil Bio, Inc. other research and development expense for fiscal 2025 was $779.00K, a 62.29% decline from fiscal 2024.
- Instil Bio, Inc. other research and development expense for fiscal 2024 was $2.07M.
| Period end | Other Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $779.00K 10-K · filed 2026-03-27 |
| 2024-12-31 | $2.07M 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |